Liver fibrosis
- PMID: 29391303
- PMCID: PMC6322608
- DOI: 10.5152/tjg.2018.17330
Liver fibrosis
Abstract
Liver fibrosis is a wound-healing response generated against an insult to the liver that causes liver injury. It has the potential to progress into cirrhosis, and if not prevented, it may lead to liver cancer and liver failure. The activation of hepatic stellate cells (HSCs) is the central event underlying liver fibrosis. In addition to HSCs, numerous studies have supported the potential contribution of bone marrow-derived cells and myofibroblasts to liver fibrosis. The liver is a heterogeneous organ; thus, molecular and cellular events that underlie liver fibrogenesis are complex. This review aims to focus on major events that occur during liver fibrogenesis. In addition, important antifibrotic therapeutic approaches and experimental liver fibrosis models will be discussed.
Conflict of interest statement
References
-
- Bataller R, Brenner DA. Liver fibrosis. J Clin Invest. 2005;115:209–18. https://doi.org/10.1172/JCI24282 - DOI - PMC - PubMed
-
- Kisseleva T, Brenner DA. Mechanisms of fibrogenesis. Exp Biol Med. 2008;233:109–22. https://doi.org/10.3181/0707-MR-190 - DOI - PubMed
-
- Ekihiro S, Brenner DA. Recent advancement of molecular mechanisms of liver fibrosis. J Hepatobiliary Pancreat Sci. 2015;22:512–8. https://doi.org/10.1002/jhbp.245 - DOI - PMC - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical